Divi's Laboratories (BOM:532488) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:532488 Divi's Laboratories Ltd BOM:532488
93 GF Score
Price ₹8,056.65
GF Value ₹6,796.35
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Divi's Laboratories Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

BOM:532488 vs ZTS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Divi's Laboratories's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Divi's Laboratories Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Divi's Laboratories's Short Interest distribution charts can be found below:

* The bar in red indicates where Divi's Laboratories's Short Interest falls into.


BOM:532488
93GF Score
Divi's Laboratories Ltd BOM:532488
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Divi's Laboratories (BOM:532488) Overvalued in 2026?

Based on GuruFocus' analysis, Divi's Laboratories stock appears to be overvalued. The current stock price of ₹8,056.65 is trading 18.5% above its estimated GF Value™ of ₹6,796.35. GuruFocus considers Divi's Laboratories to be Modestly Overvalued.

Key valuation signals for BOM:532488:

  • Short Interest:
  • GF Value™: ₹6,796.35 vs. price of ₹8,056.65 (18.5% above fair value)
  • GF Score™: 93/100 with 7 warning signs

No single metric tells the full story. See the BOM:532488 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Divi's Laboratories Business Description

Other Exchanges DIVISLAB:India
Address Cyber Hills, Divi Towers, 1-72/23(P)/DIVIS/303, Gachibowli, Hyderabad, TG, IND, 500032
Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. It is engaged in the manufacture of Active Pharmaceutical ingredients (API), Intermediates, and Nutraceutical ingredients, with a predominance in exports. It also, through its custom synthesis, supports pharma companies for their patented products business from gram-scale requirements for clinical trials to launch, as well as late-life cycle management. Geographically, the company derives maximum revenue from Europe, and the rest from America, India, Asia (excluding India), and the Rest of the world.
93GF Score

Get the complete analysis for BOM:532488

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹8,056.65
Price
₹6,796.35
GF Value